| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |